The ban on Nimesulide in India follows growing concerns about its safety, particularly its potential for liver damage. Previously a popular over-the-counter painkiller for its quick relief, its widespread use, often without medical guidance, concealed underlying issues and delayed diagnoses. Regulators have now restricted its use due to emerging evidence of significant risks with increased dosage and duration.
